NASDAQ:SIBN • US8257041090
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SI-BONE INC (SIBN).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-24 | TD Cowen | Maintains | Buy -> Buy |
| 2026-02-24 | Truist Securities | Reiterate | Buy -> Buy |
| 2026-01-27 | TD Cowen | Initiate | Buy |
| 2025-12-18 | Truist Securities | Maintains | Buy -> Buy |
| 2025-12-17 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-12-16 | Needham | Maintains | Buy -> Buy |
| 2025-12-02 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-10-15 | Truist Securities | Maintains | Buy -> Buy |
| 2025-08-05 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-05-06 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-05-06 | Needham | Reiterate | Buy -> Buy |
| 2025-05-06 | Truist Securities | Maintains | Buy -> Buy |
| 2025-02-25 | Citizens Capital Markets | Reiterate | Market Outperform -> Market Outperform |
| 2025-02-25 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-02-25 | Needham | Maintains | Buy -> Buy |
| 2025-02-25 | Truist Securities | Reiterate | Buy -> Buy |
| 2025-01-13 | Needham | Reiterate | Buy -> Buy |
| 2024-11-20 | Needham | Reiterate | Buy -> Buy |
| 2024-11-13 | Needham | Reiterate | Buy -> Buy |
| 2024-11-13 | Truist Securities | Maintains | Buy -> Buy |
| 2024-10-14 | Truist Securities | Maintains | Buy -> Buy |
| 2024-08-06 | Needham | Maintains | Buy -> Buy |
| 2024-08-06 | Truist Securities | Maintains | Buy -> Buy |
| 2024-08-06 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2024-07-15 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 138.886M 30.53% | 167.178M 20.37% | 200.925M 20.19% | 234.86M 16.89% | 269.98M 14.95% | 311.46M 15.36% | 357.2M 14.69% | 408.1M 14.25% | |
| EBITDA YoY % growth | -41.503M 26.09% | -30.869M 25.62% | -16.56M 46.35% | 10.232M 161.79% | 19.073M 86.41% | 34.881M 82.88% | 55.896M 60.25% | 76.806M 37.41% | |
| EBIT YoY % growth | -46.931M 21.26% | -35.248M 24.89% | -22.33M 36.65% | -23.964M -7.32% | -16.546M 30.96% | -6.858M 58.55% | 3.978M 158.00% | 19.686M 394.87% | |
| Operating Margin | -33.79% | -21.08% | -11.11% | -10.20% | -6.13% | -2.20% | 1.11% | 4.82% | |
| EPS YoY % growth | -1.14 36.31% | -0.76 33.33% | -0.44 42.11% | -0.52 -17.95% | -0.39 24.98% | -0.27 31.88% | 0.05 119.23% | 0.33 540.00% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.19 -25.87% | -0.16 -17.01% | -0.11 -4.32% | -0.11 -165.94% |
| Revenue Q2Q % growth | 52.393M 10.79% | 57.15M 17.52% | 56.608M 16.34% | 66.244M 17.56% |
| EBITDA Q2Q % growth | 57.559K 100.93% | 1.479M 133.94% | 2.769M 321.34% | 3.94M 19.14% |
| EBIT Q2Q % growth | -8.798M -17.62% | -7.621M -8.81% | -5.302M 1.50% | -4.649M -88.74% |
All data in USD
16 analysts have analysed SIBN and the average price target is 25.91 USD. This implies a price increase of 87.67% is expected in the next year compared to the current price of 13.805.
SI-BONE INC (SIBN) will report earnings on 2026-05-04.
The consensus EPS estimate for the next earnings of SI-BONE INC (SIBN) is -0.19 USD and the consensus revenue estimate is 52.39M USD.
The number of analysts covering SI-BONE INC (SIBN) is 16.